We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Blood Glucose in Hospitalized Patients Predicts Diabetes Risk

By LabMedica International staff writers
Posted on 03 Sep 2014
Print article
Image: The three year risk of type 2 diabetes by admission glucose. The solid line represents the estimate and the ribbon represents the 95% confidence intervals (Graph courtesy of the Public Library of Science).
Image: The three year risk of type 2 diabetes by admission glucose. The solid line represents the estimate and the ribbon represents the 95% confidence intervals (Graph courtesy of the Public Library of Science).
Blood glucose levels measured in hospitalized adults during acute illness can be used to predict the risk of developing type 2 diabetes over the following three years.

Many patients admitted to hospital because of an acute illness have hyperglycemia, an abnormally high blood glucose level which can be caused by the drugs that patients are taking for existing conditions or may be stress hyperglycemia.

Scientists at the University of Edinburgh (UK) carried out a retrospective cohort study on patients aged 30 years or older with an emergency admission to hospital between 2004 and 2008. They obtained measurements of blood glucose levels on admission for 86,634 patients who were admitted to a hospital for an acute illness and identified those patients who developed type 2 diabetes up to December 2011.

The investigators found that the overall three year risk of developing type 2 diabetes was 2.3%, with the risk of developing diabetes increased linearly with increasing blood glucose level at admission. The three year risk of type 2 diabetes was 1% for patients with a glucose level of less than 5 mmol/L (90 mg/dL) and increased to approximately 15% for patients with glucose of 15 mmol/L (270 mg/dL) or more. The team developed a risk calculator that uses the patient's age, sex, and admission blood glucose level to predict risk of developing diabetes over three years following hospital admission.

The scientists confirm that single measures using the WHO cut-points for diagnosing diabetes, which are not based upon studies that measured glucose in the emergency setting cannot be directly applied in acutely unwell patients with hyperglycemia. They found that 90% of patients with admission glucose of 11.1 mmol/L (200 mg/dL) were not diagnosed with diabetes within three years of discharge from the hospital.

The authors conclude that the three year risk of type 2 diabetes was less than 1% for patients with a glucose of less than or equal to 5 mmol/L and increased linearly to approximately 15% at 15 mmol/L, above which there was no further increase in risk. Mortality was also 1.5-fold higher in patients with glucose levels of 11.1 to 15 mmol/L compared to those with glucose levels less than 6.1 mmol/L. These findings can be used to inform individual patients of their long-term risk of type 2 diabetes and to offer lifestyle advice as appropriate. The study was published on August 19, 2014, in the journal Public Library of Science Medicine.

Related Links:

University of Edinburgh


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: Ultrasound-based duplex sonography combined with a new genetic testing procedure can identify clonal haematopoiesis (Photo courtesy of 123RF)

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk

A key interest area in cardiovascular research today is the impact of clonal hematopoiesis on cardiovascular diseases. Clonal hematopoiesis results from mutations in hematopoietic stem cells and may lead... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.